查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
蛋白质定序市场规模、份额及成长分析（按产品、应用、最终用户和地区划分）－产业预测（2026-2033 年）
市场调查报告书
商品编码
1897616

蛋白质定序市场规模、份额及成长分析（按产品、应用、最终用户和地区划分）－产业预测（2026-2033 年）

Protein Sequencing Market Size, Share, and Growth Analysis, By Product (Protein Sequencing Products, Protein Sequencing Services), By Application (Biomarker Discovery, Protein Engineering Studies), By End-User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年，蛋白质定序市场价值将达到 13.9 亿美元，到 2025 年将成长至 14.4 亿美元，到 2033 年将成长至 18.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 3.5%。

蛋白质定序是一种利用质谱分析来确定胺基酸序列的先进技术，能够更深入地了解蛋白质结构。这种高通量蛋白质体学方法在各个应用领域，尤其是在标靶药物研发领域，正日益受到关注。生技和製药公司对标靶药物研发的日益重视是推动市场扩张的主要动力。此外，各国对蛋白质体学研究投入的不断增加也促进了产业发展。药物研发中对蛋白质生物标记的需求不断增长，进一步刺激了市场需求。未来标靶药物设计的进步以及基因工程领域的持续研究将继续推动蛋白质定序技术的演进，为该领域的创新和发展创造巨大机会。

蛋白质定序市场驱动因素

蛋白质定序市场的成长可归因于临床质谱技术的进步和分析方法的日益精细化。这些创新预计将显着推动该领域的需求。此外，公共和私营机构对蛋白质体学研究投入的不断增加也将对市场扩张起到关键的促进作用。随着更多资源投入阐明蛋白质结构和功能的研究，市场有望受益于投资和关注的提升，从而促进其进一步发展。技术进步与资金支持的融合，正为蛋白质定序领域的蓬勃发展奠定基础。

蛋白质定序市场限制因素

蛋白质定序市场的成长面临许多挑战，主要源自于基础建设的高昂成本。熟练的研究人员和实验室人员短缺，而他们对于执行高级定序任务至关重要，这构成了另一个障碍。此外，製备高纯度蛋白质样本的需求进一步增加了复杂性和成本，阻碍了市场的广泛扩张。这些因素共同作用，极大地阻碍因素了市场的潜力，因为相关人员必须在管理最尖端科技投资的同时，应对资源分配和人才培养方面的复杂挑战。

蛋白质定序市场趋势

蛋白质定序市场正经历显着成长，这主要得益于蛋白质工程技术的进步以及对包括抗体和疫苗在内的创新生物製剂日益增长的需求。将非天然胺基酸引入特定位点进行精确偶联，正在革新生物製药的研发。转译后修饰技术的进步和菌株开发的改进，使得蛋白质产品的精准性得以提升，并加快了生物製药的核准流程。这一趋势反映了为满足治疗需求而向更先进的蛋白质工程方向发展的广泛趋势，为市场参与者在不断变化的医疗保健环境中进行创新并提高药物研发效率提供了盈利的机会。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术进步
  • 监管环境
  • 专利分析
  • 案例研究

全球蛋白质定序市场规模（依产品/服务划分）及复合年增长率（2026-2033 年）

  • 蛋白质定序产品
    • 试剂和耗材
    • 装置
    • 质谱分析
    • 艾德曼分解
    • 软体
  • 蛋白质定序服务
    • 样品製备服务
    • 定序服务
    • 数据分析服务

全球蛋白质定序市场规模（按应用领域划分）及复合年增长率（2026-2033 年）

  • 生物标记发现
  • 蛋白质工程研究
  • 生物治疗
  • 其他的
    • 结构生物学
    • 药物发现

全球蛋白质定序市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

  • 製药和生物技术公司
  • 研究中心
  • 学术机构
  • 其他的
    • 受託研究机构（CRO）
    • 诊断实验室

全球蛋白质定序市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2021-2023年营收年比比较

主要企业简介

  • Thermo Fisher Scientific Inc.（USA）
  • Agilent Technologies, Inc.（USA）
  • Bioinformatics Solutions Inc.（Canada）
  • Shimadzu Corporation（Japan）
  • Waters Corporation（USA）
  • Bruker Corporation（USA）
  • Danaher Corporation（USA）
  • PerkinElmer, Inc.（USA）
  • Charles River Laboratories International, Inc.（USA）
  • QIAGEN NV（Netherlands）
  • Merck KGaA（Germany）
  • GenScript Biotech Corporation（China）
  • Creative Proteomics（USA）
  • Bio-Rad Laboratories, Inc.（USA）
  • Promega Corporation（USA）
  • Pacific Biosciences of California, Inc.（USA）
  • Oxford Nanopore Technologies Ltd.（UK）
  • Illumina, Inc.（USA）
  • Becton, Dickinson and Company（USA）
  • Eurofins Scientific（Luxembourg）

结论与建议

简介目录
Product Code: SQSG35H2025

Protein Sequencing Market size was valued at USD 1.39 Billion in 2024 and is poised to grow from USD 1.44 Billion in 2025 to USD 1.89 Billion by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).

Protein sequencing is an advanced technique that determines amino acid sequences through mass spectrometry, enhancing understanding of protein structures. This high-throughput proteomic method has gained traction across various applications, particularly in target-based drug discovery. The increasing emphasis on targeted medication development by biotechnology and pharmaceutical firms is a key driver of market expansion. Additionally, rising investments in proteomics research across different nations contribute to industry growth. The growing need for protein biomarkers in drug development further accelerates market demand. Anticipated advancements in target-based drug design and ongoing research in genetic engineering will continue to propel the evolution of protein sequencing technologies, creating significant opportunities for innovation and growth within the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Sequencing Market Segments Analysis

Global Protein Sequencing Market is segmented by product, application, end-user and region. Based on product, the market is segmented into protein sequencing products and protein sequencing services. Based on application, the market is segmented into biomarker discovery, protein engineering studies, biotherapeutics and others. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, research centers, academic institutions and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Sequencing Market

The anticipated growth of the protein sequencing market can be attributed to advancements in clinical mass spectrometry and enhanced analytical techniques. These innovations are expected to significantly drive demand in the sector. Additionally, increased funding from both public and private organizations for proteomic research plays a crucial role in stimulating market expansion. As more resources are allocated towards understanding protein structures and functions, the market is likely to benefit from heightened investment and interest, further contributing to its development. This convergence of technological progress and financial backing sets the stage for a robust evolution in the protein sequencing landscape.

Restraints in the Protein Sequencing Market

The growth of the Protein Sequencing market faces significant challenges primarily due to the substantial costs associated with infrastructure. Furthermore, the limited availability of skilled researchers and laboratory personnel poses an additional barrier, as these professionals are essential for conducting advanced sequencing tasks. Moreover, the necessity of generating high-purity protein samples adds another layer of complexity and expense, hindering broader market expansion. These factors collectively create a formidable restraint on the market's potential, as stakeholders must navigate the complexities of resource allocation and personnel training while managing financial investments in cutting-edge technologies.

Market Trends of the Protein Sequencing Market

The Protein Sequencing market is experiencing a significant surge driven by advancements in protein engineering and the growing demand for innovative bioformulations, including antibodies and vaccines. The focus on incorporating unnatural amino acids for precise site-specific conjugation is revolutionizing the development of biopharmaceuticals. Enhanced post-translational engineering techniques and improved strain development are leading to better-defined protein products, facilitating expedited approval processes for biopharmaceuticals. This trend reflects a broader shift toward more sophisticated protein manipulation to meet therapeutic needs, presenting lucrative opportunities for market players to innovate and enhance drug development efficiency in the evolving healthcare landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Protein Sequencing Market Size by Product & Service & CAGR (2026-2033)

  • Market Overview
  • Protein Sequencing Products
    • Reagents & Consumables
    • Instruments
    • Mass Spectrometry
    • Edman Degradation
    • Software
  • Protein Sequencing Services
    • Sample Preparation Services
    • Sequencing Services
    • Data Analysis Services

Global Protein Sequencing Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Biomarker Discovery
  • Protein Engineering Studies
  • Biotherapeutics
  • Others
    • Structural Biology
    • Drug Discovery

Global Protein Sequencing Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Research Centers
  • Academic Institutions
  • Others
    • Contract Research Organizations (CROs)
    • Diagnostic Laboratories

Global Protein Sequencing Market Size & CAGR (2026-2033)

  • North America (Product & Service, Application, End-User)
    • US
    • Canada
  • Europe (Product & Service, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product & Service, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product & Service, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product & Service, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioinformatics Solutions Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenScript Biotech Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Proteomics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations